PL2236598T3 - Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenu - Google Patents

Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenu

Info

Publication number
PL2236598T3
PL2236598T3 PL08865212T PL08865212T PL2236598T3 PL 2236598 T3 PL2236598 T3 PL 2236598T3 PL 08865212 T PL08865212 T PL 08865212T PL 08865212 T PL08865212 T PL 08865212T PL 2236598 T3 PL2236598 T3 PL 2236598T3
Authority
PL
Poland
Prior art keywords
microorganisms
individuals
health
improving
disorders related
Prior art date
Application number
PL08865212T
Other languages
English (en)
Inventor
Herranz Yolanda Sanz
Sanchez Ester Sanchez
Marcela Susana Medina
Palma Giada De
Gimenez Inmaculada Nadal
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Publication of PL2236598T3 publication Critical patent/PL2236598T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PL08865212T 2007-12-24 2008-12-23 Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenu PL2236598T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200703427A ES2343499B1 (es) 2007-12-24 2007-12-24 Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
EP08865212A EP2236598B1 (en) 2007-12-24 2008-12-23 Microorganisms for improving the health of individuals with disorders related to gluten ingestion
PCT/ES2008/070243 WO2009080862A1 (es) 2007-12-24 2008-12-23 Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten

Publications (1)

Publication Number Publication Date
PL2236598T3 true PL2236598T3 (pl) 2013-08-30

Family

ID=40800750

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08865212T PL2236598T3 (pl) 2007-12-24 2008-12-23 Drobnoustroje do poprawy stanu zdrowia osobników z zaburzeniami związanymi ze spożyciem glutenu

Country Status (16)

Country Link
US (1) US8501169B2 (pl)
EP (1) EP2236598B1 (pl)
JP (1) JP5693232B2 (pl)
KR (1) KR20100110341A (pl)
CN (1) CN101983237B (pl)
AU (1) AU2008341708B2 (pl)
BR (1) BRPI0819533B1 (pl)
CA (1) CA2710666C (pl)
CY (1) CY1113848T1 (pl)
DK (1) DK2236598T3 (pl)
ES (2) ES2343499B1 (pl)
MX (1) MX2010007038A (pl)
PL (1) PL2236598T3 (pl)
PT (1) PT2236598E (pl)
SI (1) SI2236598T1 (pl)
WO (1) WO2009080862A1 (pl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110081320A1 (en) * 2009-10-06 2011-04-07 Nubiome, Inc. Treatment/Cure of Autoimmune Disease
US20140187474A1 (en) * 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
IN2014DN07752A (pl) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
FI127483B (en) 2014-06-11 2018-07-13 Gut Guide Oy Microbial marker for celiac disease and related product
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
EP3222281B1 (en) * 2014-11-19 2020-01-08 Kabushiki Kaisha Yakult Honsha Preventive and therapeutic agent for celiac disease
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
GB201515557D0 (en) * 2015-09-02 2015-10-14 14M Genomics Ltd Method of sequencing
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
EP3222282A1 (en) * 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
TWI802545B (zh) 2016-07-13 2023-05-21 英商4D製藥有限公司 包含細菌菌株之組合物
EP3272396A1 (en) 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US20200061131A1 (en) * 2016-12-16 2020-02-27 Vedanta Biosciences, Inc. Methods and compositions for determining bacterial integrity
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3638271T3 (pl) 2017-06-14 2021-03-22 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
JP7273824B2 (ja) * 2017-12-29 2023-05-15 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
WO2020069282A1 (en) * 2018-09-27 2020-04-02 Research Development Foundation Methods and probiotic compositions for the treatment of bone disorders
EP3920908A4 (en) * 2019-02-08 2022-10-05 McMaster University USE OF HYDROCARBON RECEPTOR ACTIVATORS IN THE TREATMENT OF GLUTEN-INDUCED GASTROINTESTINAL DISEASES
CN114402062B (zh) * 2019-07-01 2025-02-25 雀巢产品有限公司 产生丝氨酸蛋白酶抑制剂
CN114555635B (zh) * 2019-07-01 2024-12-17 雀巢产品有限公司 产生丝氨酸蛋白酶抑制剂
AU2020412216A1 (en) * 2019-12-23 2022-08-18 Evonik Operations Gmbh Process to identify consortia of probiotic strains suitable for gluten degradation
CN114845571A (zh) 2019-12-23 2022-08-02 赢创运营有限公司 用于麸质降解的包含至少一种芽孢杆菌属和乳杆菌属菌株的细菌聚生体
EP3851115A1 (en) * 2020-01-15 2021-07-21 Biopolis, S.L. Probiotic composition for its use as an antioxidant
CN112694992B (zh) * 2020-12-30 2023-02-21 江南大学 一株可缓解腹泻的两歧双歧杆菌及其应用
CN115400154A (zh) * 2022-08-10 2022-11-29 深圳未知君生物科技有限公司 长双歧杆菌在制备治疗自闭症谱系障碍的药物中的应用
ES3008845A1 (es) 2023-09-22 2025-03-25 Consejo Superior Investigacion Proteína degradadora de gluten y usos de la misma

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285526B2 (en) 1995-07-14 2007-10-23 Meiogen Biotechnology Corporation Interferon antagonists useful for the treatment of interferon related diseases
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6562943B1 (en) 1999-04-21 2003-05-13 Zycos, Inc. Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
US7320788B2 (en) 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
US7202216B2 (en) 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
GB0323039D0 (en) * 2003-10-01 2003-11-05 Danisco Method
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7563864B2 (en) * 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
US8071101B2 (en) * 2005-11-03 2011-12-06 Avaxia Biologics, Inc. Antibody therapy for treatment of diseases associated with gluten intolerance
AR060103A1 (es) 2006-02-09 2008-05-28 Alba Therapeutics Corp Formulaciones para un efector de uniones apretadas
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease

Also Published As

Publication number Publication date
CY1113848T1 (el) 2016-07-27
ES2402183T3 (es) 2013-04-29
ES2343499B1 (es) 2011-06-10
US20100310520A1 (en) 2010-12-09
JP5693232B2 (ja) 2015-04-01
ES2343499A1 (es) 2010-08-02
EP2236598A4 (en) 2012-01-25
PT2236598E (pt) 2013-04-02
JP2011507540A (ja) 2011-03-10
EP2236598B1 (en) 2012-12-26
DK2236598T3 (da) 2013-04-02
AU2008341708B2 (en) 2014-07-17
BRPI0819533A2 (pt) 2014-10-14
BRPI0819533B1 (pt) 2018-06-05
CA2710666A1 (en) 2009-07-02
EP2236598A1 (en) 2010-10-06
CN101983237B (zh) 2013-06-12
US8501169B2 (en) 2013-08-06
WO2009080862A1 (es) 2009-07-02
AU2008341708A1 (en) 2009-07-02
KR20100110341A (ko) 2010-10-12
CN101983237A (zh) 2011-03-02
CA2710666C (en) 2018-12-04
MX2010007038A (es) 2010-10-15
SI2236598T1 (sl) 2013-08-30

Similar Documents

Publication Publication Date Title
SI2236598T1 (sl) Mikroorganizmi za izboljšanje zdravja posameznikov z motnjami, ki se nanašajo na uživanje glutena
ZA201000246B (en) Improvements relating to the fitting of spectacles
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
IL204886A0 (en) Methods of treating gastrointestinal disorders independent of the intake of food
AU2008233088A8 (en) Calcimimetic compounds for use in the treatment of bowel disorders
GB0902537D0 (en) Improvememts in or relating to the creation of curved forms
PL385440A1 (pl) Sposób wytwarzania 4'-O- -D-glukozylo-2',4-dihydroksy-6'-metoksy-3'-prenylochalkonu
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
IL207647A0 (en) Use of interleukin-1 conjugates in the treatment of diabetes
WO2010085799A9 (en) Compositions and method for the treatment of parkinson's disease
EP2225559B8 (en) Assessment of physiological conditions
GB0720400D0 (en) Improvements in or relating to the preparation of beverages
GB0902538D0 (en) Improvvements in or relating to the creation of curved forms
IL206128A0 (en) Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
PL383170A1 (pl) Sposób otrzymywania preparatu wapniowego
GB0814043D0 (en) The treatment of skin disorders
GB2432276B (en) Connecting to the internet
HK1146216A (en) Use of interleukin-1 conjugates in the treatment of diabetes
PL379558A1 (pl) Sposób otrzymywania preparatu enzymów
PL379557A1 (pl) Sposób otrzymywania preparatu enzymów
AU2008904643A0 (en) Joint and arthritis health formula
GB0711369D0 (en) Improvements to the measurement of daily activity
GB0720032D0 (en) Improvements relating to the entrapment of fine particulates
AU2007900485A0 (en) Indentifying Persons Susceptible to Pathological Myopia
AU2008903823A0 (en) Health Supplement Compositions